The Pharmaceutical Cold Chain Packaging Industry in the United States is entering a decade of accelerated expansion, driven by rising biologics demand, ongoing vaccine distribution, and tighter compliance frameworks. Valued at USD 4.9 billion in 2025, the market is projected to reach an impressive USD 13.8 billion by 2035, registering a robust CAGR of 10.9%.
As the pharmaceutical sector continues its shift toward temperature-sensitive therapies including mRNA vaccines, monoclonal antibodies, and cell & gene therapies, cold chain packaging is becoming indispensable to ensuring product integrity across domestic and global supply networks.
Subscribe for Year-Round Insights → Stay ahead with quarterly and annual data updates – https://www.futuremarketinsights.com/reports/sample/rep-gb-22371
Quick Market Snapshot
- Market Size (2025): USD 4.9 billion
- Forecast Size (2035): USD 13.8 billion
- CAGR (2025–2035): 10.9%
- Top Segment (2035): Active Packaging – 79.8% share
- Leading Product Type: Boxes – 60% share
- Key Companies: Sealed Air, PeliBioThermal, CSafe, Intelsius, Sonoco ThermoSafe, Cryoport Systems
A Growing Pillar in the U.S. Pharma & Logistics Ecosystem
In 2025, cold chain packaging represents 4–6% of the broader pharmaceutical packaging sector and close to 15–20% of the temperature-sensitive packaging market. The category’s significance is rising rapidly as the U.S. continues to scale biologic production, expand clinical trial pipelines, and invest in high-performance logistics systems.
A notable strategic development occurred in December 2024, when Knipper Health acquired Thermo Fisher Scientific’s sample management facility in Memphis. According to CEO Michael LaFerrera, the move strengthens their national cold chain footprint and leverages Memphis’ proximity to the FedEx World Hub, a critical link in expedited pharmaceutical logistics. The acquisition underscores a national trend: companies are scaling cold chain infrastructure near key distribution corridors to ensure faster, safer delivery of life-saving therapies.
Market Leaders by Investment Segment
Refrigerated Temperature Control Dominates
Refrigerated solutions are expected to hold 45% share in 2025, driven by widespread use in transporting vaccines, biologics, and injectable therapies. While frozen and deep-frozen ranges support niche applications—such as plasma and cell therapies their higher operational cost limits adoption to specialized products.
EPS Leads Substrate Category
Expanded Polystyrene (EPS) remains the most widely used substrate, capturing 35% of the market due to its superior insulation, lightweight design, and regulatory compliance. Polyurethane (PU) and Vacuum Insulated Panels (VIPs) are on the rise for premium applications but remain cost-restricted.
Boxes Remain the Backbone of Cold Chain Distribution
Boxes lead the product segment with a commanding 60% market share, owing to their versatility, durability, and ability to support multilayer insulation, phase-change materials, and tamper-proof systems. Pallets and mailers serve important but secondary roles in specialized and bulk shipments.
Coolants to Capture 65% Share in 2025
Coolants including gel packs, dry ice, and phase-change materials, are set to maintain dominance, supporting the stability of specialty drugs during long-distance transport. Investments in bio-based, reusable, and smart coolant systems are beginning to reshape this category.
Biopharmaceutical Companies Lead Application Share
Biopharmaceutical companies are projected to hold 50% market share as next-generation therapies demand high-precision cold chain systems. CROs, hospitals, and logistics companies represent growing but smaller user groups.
Regional Growth Outlook: Top U.S. States Leading the Market
Between 2025 and 2035, the U.S. cold chain packaging market will be shaped significantly by five core states with advanced biotech ecosystems and logistics infrastructure.
| State | CAGR (2025–2035) |
| California | 5.9% |
| Texas | 5.5% |
| New York | 5.4% |
| Pennsylvania | 5.2% |
| Illinois | 5.1% |
California leads due to its strong biotech presence and sustainability-focused packaging initiatives. Texas follows with expanding warehousing capacity and cross-border USMCA trade activity. New York strengthens cold chain demand through its dense healthcare and research ecosystems. Pennsylvania and Illinois are critical logistics corridors supporting biologics movement across the Mid-Atlantic and Midwest.
Market Drivers & Challenges
Key Growth Drivers
- Rising production of biologics and gene therapies
- Stricter FDA and GDP compliance regulations
- Rapid expansion of vaccine and specialty pharma logistics
- Adoption of active packaging with real-time monitoring
Challenges
- High costs associated with active cold chain packaging systems
- Regulatory pressure on plastic and polystyrene waste
- Infrastructure limitations for ultra-cold therapy transport
Competitive Landscape
The U.S. cold chain packaging market is moderately consolidated. Sealed Air, PeliBioThermal, CSafe, and Sonoco ThermoSafe lead with advanced active and passive systems. Cryoport Systems, SkyCell, and Intelsius continue to expand capabilities in cryogenic transport and biotech packaging. New entrants are focusing on recyclable insulation, lightweight shippers, and AI-based route optimization.
Recent Industry Update
March 2025: DHL Group announced the acquisition of CryoPDP, expanding its global cold chain network and reinforcing end-to-end logistics capabilities for high-value pharmaceuticals.
Why FMI: https://www.futuremarketinsights.com/why-fmi
About Future Market Insights (FMI)
Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S., UK, India, and Dubai, FMI provides data-backed insights and strategic intelligence across 30+ industries and 1200 markets worldwide.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
